Back
NovoCure Stock Price Chart

Unveiling AI's $2 Trillion Opportunity!
Grab your FREE guide before it's gone. Click here Now!
Sell
38
NVCR
NovoCure
Last Price:
12.51
Seasonality Move:
-1.62%
7 Day Trial
ALL ACCESS PASS
$
7

Wall Street Insider Makes Prediction about Hot A.I. Stock
Learn more here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVCR is experiencing slight selling pressure.
NovoCure Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.64 | Sell |
20-day SMA: | 12.31 | Buy |
50-day SMA: | 13.36 | Sell |
200-day SMA: | 40.22 | Sell |
8-day EMA: | 12.62 | Sell |
20-day EMA: | 12.63 | Sell |
50-day EMA: | 14.73 | Sell |
200-day EMA: | 35.98 | Sell |
NovoCure Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 45.95 | Sell |
Chaikin Money Flow: | -17447 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.8 - 12.94) | Buy |
Bollinger Bands (100): | (11.63 - 27.99) | Sell |
NovoCure Technical Analysis
Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | Dec 4 | Dec 5 | Dec 6 | Dec 7 | Dec 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 28 | 29 | 30 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for NovoCure Stock
Is NovoCure Stock a Buy?
- NovoCure share price is 12.50 while NVCR 8-day simple moving average is 12.64, which is a Sell signal.
- The stock price of NVCR is 12.50 while NovoCure 20-day SMA is 12.31, which makes it a Buy.
- NovoCure 50-day simple moving average is 13.36 while NVCR share price is 12.50, making it a Sell technically.
- NVCR stock price is 12.50 and NovoCure 200-day simple moving average is 40.22, creating a Sell signal.
NVCR Technical Analysis vs Fundamental Analysis
NovoCure Stock Info
Market Cap:
1.34B
Price in USD:
12.50
Share Volume:
954.58K
NovoCure 52-Week Range
52-Week High:
120.03
52-Week Low:
10.87
Sell
38
NovoCure (NVCR)
is a Sell
NovoCure Share Price Forecast
-
What is the NovoCure stock price today?
The NovoCure stock price is 12.50 USD today. -
Will NVCR stock go up or go down?
NovoCure> share price is forecast to RISE/FALL based on technical indicators -
Is NovoCure overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovoCure is overvalued.
Is NovoCure Stock a Buy?
- NovoCure share price is 12.50 while NVCR 8-day exponential moving average is 12.62, which is a Sell signal.
- The stock price of NVCR is 12.50 while NovoCure 20-day EMA is 12.63, which makes it a Sell.
- NovoCure 50-day exponential moving average is 14.73 while NVCR share price is 12.50, making it a Sell technically.
- NVCR stock price is 12.50 and NovoCure 200-day simple moving average is 35.98, creating a Sell signal.
Fundamental Analysis of NovoCure
Is NovoCure a good investment?
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.20 per share, and an increase next year of $0.07 per share.
Technical Analysis of NovoCure
Should I short NovoCure stock?
- NVCR Moving Average Covergence Divergence (MACD) indicator is -0.25, suggesting NovoCure is a Sell
- NovoCure Relative Strength Index (RSI) is 45.95, which suggest NovoCure is oversold
- The Bollinger Bands (25) for NovoCure is (11.8 - 12.94), which suggest NovoCure is a Sell
- The Bollinger Bands (100) for NovoCure is (11.63 - 27.99), which suggest NovoCure is a Sell
* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.